Mobilization of lysosome anti-microbial defenses by the unfolded protein response

通过未折叠的蛋白质反应动员溶酶体抗微生物防御

基本信息

  • 批准号:
    8519298
  • 负责人:
  • 金额:
    $ 17.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Professional phagocytes play a critical role in anti-microbial defense. Uptake of microbes by phagocytosis results in the formation of a dynamic vesicular compartment, termed the phagolysosome. The phagolysosome physically and functionally defines a critical separation of the microbe from the host cell, allowing the host to target degradative anti-microbial mechanisms to this confined space. We find that bacterial infection triggers the unfolded protein response (UPR), a cellular program associated with ER stress and innate immune function. Activation of the UPR increases the capacity of the cell to degrade proteins, but the mechanisms responsible for this degradation are incompletely understood. Our preliminary studies suggest that UPR activation during bacterial infection results in increased association of methicillin resistant Staphylococcus aureus (MRSA) with the degradative lysosomal compartment and bacterial killing. Inhibition of specific UPR regulators results in decreased association with lysosomes and decreased MRSA killing. The central hypothesis of this proposal is that activation of the UPR in phagocytes results in increased trafficking and degradative capacity of the phagolysosomal network, leading to enhanced degradative, and thus anti-microbial, function. To test this hypothesis, we will (1) measure mobilization of the lysosomal network using physical and functional markers upon activation of the UPR; (2) define the role of the UPR sensors, Ire1, ATF6 and PERK in regulating specific aspects of lysosomal trafficking and function in response to innate immune signals during infection. Regulation of the degradative capacity of the cell by the UPR is a fundamental strategy by which cells can respond to perturbations in the production or secretion of proteins. Our studies now highlight a novel connection between UPR-mediated degradation and anti-microbial function, and will define key druggable targets that shape the macrophage anti-microbial arsenal for development of anti-infective strategies.
描述(由申请人提供):专职吞噬细胞在抗微生物防御中发挥关键作用。通过吞噬作用摄取微生物导致形成动态囊泡隔室,称为吞噬溶酶体。吞噬溶酶体在物理上和功能上定义了微生物与宿主细胞的关键分离,允许宿主将降解性抗微生物机制靶向该密闭空间。我们发现细菌感染触发未折叠蛋白反应(UPR),这是一种与ER应激和先天免疫功能相关的细胞程序。UPR的激活增加了细胞降解蛋白质的能力,但这种降解的机制还不完全清楚。我们的初步研究表明,在细菌感染过程中UPR激活的结果增加与耐甲氧西林金黄色葡萄球菌(MRSA)的降解溶酶体区室和细菌杀灭的关联。特异性UPR调节剂的抑制导致与溶酶体的结合减少和MRSA杀伤减少。该提议的中心假设是,吞噬细胞中UPR的激活导致吞噬溶酶体网络的运输和降解能力增加,导致降解功能增强,从而增强抗微生物功能。为了验证这一假设,我们将(1)使用UPR激活后的物理和功能标志物测量溶酶体网络的动员;(2)定义UPR传感器Ire 1,ATF 6和PERK在感染期间响应先天免疫信号调节溶酶体运输和功能的特定方面的作用。通过UPR调节细胞的降解能力是细胞可以响应蛋白质产生或分泌中的扰动的基本策略。我们的研究现在强调了UPR介导的降解与抗微生物功能之间的新联系,并将定义关键的可药物靶点,这些靶点塑造巨噬细胞抗微生物武器库,以开发抗感染策略。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
More than a pore: the cellular response to cholesterol-dependent cytolysins.
  • DOI:
    10.3390/toxins5040618
  • 发表时间:
    2013-04-12
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Cassidy SK;O'Riordan MX
  • 通讯作者:
    O'Riordan MX
Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death having features of apoptosis and pyroptosis.
Measurement of Mitochondrial DNA Release in Response to ER Stress.
  • DOI:
    10.21769/bioprotoc.1839
  • 发表时间:
    2016-06-20
  • 期刊:
  • 影响因子:
    0.8
  • 作者:
    Bronner, Denise N;O'Riordan, Mary X
  • 通讯作者:
    O'Riordan, Mary X
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary O'Riordan其他文献

Mary O'Riordan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary O'Riordan', 18)}}的其他基金

Mitochondrial stress shapes host responses to bacterial infection
线粒体应激塑造宿主对细菌感染的反应
  • 批准号:
    10317161
  • 财政年份:
    2021
  • 资助金额:
    $ 17.72万
  • 项目类别:
Mitochondrial stress shapes host responses to bacterial infection
线粒体应激塑造宿主对细菌感染的反应
  • 批准号:
    10413242
  • 财政年份:
    2021
  • 资助金额:
    $ 17.72万
  • 项目类别:
Mitochondrial stress shapes host responses to bacterial infection
线粒体应激塑造宿主对细菌感染的反应
  • 批准号:
    10616749
  • 财政年份:
    2021
  • 资助金额:
    $ 17.72万
  • 项目类别:
Mechanisms of host defense against membrane damage by pore-forming toxins
宿主防御成孔毒素膜损伤的机制
  • 批准号:
    8699346
  • 财政年份:
    2013
  • 资助金额:
    $ 17.72万
  • 项目类别:
Targeting host deubiquitinases for broad spectrum anti-infective therapy
靶向宿主去泛素酶进行广谱抗感染治疗
  • 批准号:
    8389503
  • 财政年份:
    2012
  • 资助金额:
    $ 17.72万
  • 项目类别:
Targeting host deubiquitinases for broad spectrum anti-infective therapy
靶向宿主去泛素酶进行广谱抗感染治疗
  • 批准号:
    8854184
  • 财政年份:
    2012
  • 资助金额:
    $ 17.72万
  • 项目类别:
Mobilization of lysosome anti-microbial defenses by the unfolded protein response
通过未折叠的蛋白质反应动员溶酶体抗微生物防御
  • 批准号:
    8364443
  • 财政年份:
    2012
  • 资助金额:
    $ 17.72万
  • 项目类别:
Targeting host deubiquitinases for broad spectrum anti-infective therapy
靶向宿主去泛素酶进行广谱抗感染治疗
  • 批准号:
    8485542
  • 财政年份:
    2012
  • 资助金额:
    $ 17.72万
  • 项目类别:
Targeting host deubiquitinases for broad spectrum anti-infective therapy
靶向宿主去泛素酶进行广谱抗感染治疗
  • 批准号:
    8891354
  • 财政年份:
    2012
  • 资助金额:
    $ 17.72万
  • 项目类别:
Use of host derived lipoate by Listeria monocytogenes
单核细胞增生李斯特菌使用宿主来源的硫辛酸
  • 批准号:
    7050534
  • 财政年份:
    2005
  • 资助金额:
    $ 17.72万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 17.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了